GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
106 hedge funds and large institutions have $76.1M invested in Sanofi Contingent Value Rights in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
31% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 16
Holders
106
Holding in Top 10
1
Calls
$724K
Puts
–
Top Buyers
| 1 | +$322K | |
| 2 | +$169K | |
| 3 | +$122K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.5K |
| 5 |
RWP
RWA Wealth Partners
Newton,
Massachusetts
|
+$8K |
Top Sellers
| 1 | -$76.5K | |
| 2 | -$71.7K | |
| 3 | -$50K | |
| 4 |
PC
Permanens Capital
New York
|
-$48K |
| 5 |
DBG
De Burlo Group
Boston,
Massachusetts
|
-$16K |